Stay updated on Cabozantinib in Solid Tumors & HIV Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Solid Tumors & HIV Clinical Trial page.

Latest updates to the Cabozantinib in Solid Tumors & HIV Clinical Trial page
- Check5 days agoChange DetectedThe page now renders a 403 Forbidden error, replacing the usual study content. This indicates the record is unavailable and users are shown a link to the homepage.SummaryDifference22%

- Check12 days agoChange DetectedThe page's Revision tag updated from v3.6.6 to v3.7.0, indicating an update to the page template/version used for this study record.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page revision label changed from v3.6.5 to v3.6.6, indicating an internal update to the ClinicalTrials.gov page. This does not modify any study content or user-facing information.SummaryDifference0.0%

- Check48 days agoChange DetectedThe page footer revision tag updated from v3.6.4 to v3.6.5. This change reflects a version update on the site and does not alter the study content or user-facing information.SummaryDifference0.0%

- Check62 days agoChange DetectedThis is a minor site update with the revision tag changing from v3.6.3 to v3.6.4. It does not modify study data, eligibility criteria, or other user-facing content on the page.SummaryDifference0.0%

- Check84 days agoChange DetectedRevision label updated from v3.6.2 to v3.6.3. This appears to be a minor update that does not modify the study details, eligibility criteria, or participant information.SummaryDifference0.0%

Stay in the know with updates to Cabozantinib in Solid Tumors & HIV Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Solid Tumors & HIV Clinical Trial page.